Bay Area based Ridge Bio is using machine learning in the wet lab at large scale, but with a cell free platform, to develop optimized linkers for antibody-drug conjugates and precision enzymes
- May 26
- 1 min read
Co-Founder & CEO Weston Kightlinger describes the advantages of only using a cell's internal machinery rather than the entire cell in their experiments at scale, and how they are using this to help other companies develop more precisely engineered drug candidates.
.png){kind=logo}